Keyphrases
Lung Cancer Risk
44%
Genome-wide Association Study
41%
Rheumatoid Arthritis
33%
Single nucleotide Polymorphism
31%
Melanoma
27%
Lung Cancer
26%
Susceptibility Loci
23%
Genetic Variants
23%
Metastatic Melanoma
22%
Odds Ratio
22%
Genetic Architecture
19%
BRCA2
19%
CHEK2
15%
5p15.33
15%
Rare Variants
15%
Confidence Interval
14%
Parkinson's Disease
13%
Linkage Analysis
13%
Cancer Risk
12%
Risk Loci
12%
Genetic Susceptibility
11%
Risk Variant
11%
European Ancestry
11%
Combined Analysis
11%
Genotype
10%
Breast
9%
Melanoma Risk
9%
Susceptibility Genes
8%
Nicotinic Acetylcholine Receptor Genes
8%
RAD52
8%
Genetic Overlap
8%
Meta-analysis
8%
Breslow Thickness
8%
Susceptibility Marker
7%
Chromosome 5p15.33
7%
Lung Cancer in Never Smokers
7%
Biological Pathways
7%
Never-smokers
7%
Genetic Variation
7%
SNP
7%
TP53 mutation
6%
Quantitative Traits
6%
CHRNA1
6%
Titer
6%
FANCA
6%
Functional Genomics
6%
Interferon Regulatory Factor 5 (IRF5)
6%
Genome Detection
6%
PSMB9
6%
IL23R-IL12RB2
6%
Biochemistry, Genetics and Molecular Biology
Genome-Wide Association Study
100%
Single-Nucleotide Polymorphism
81%
Genetic Divergence
46%
Gene Linkage
35%
Single Nucleotide Polymorphism
32%
Genetics
22%
Genetic Susceptibility
17%
Linkage Analysis
15%
Smoking
14%
Genetic Architecture
13%
Genetic Variation
12%
Genomics
11%
RAD52
9%
CHEK2
9%
Tumor Suppressor Gene
9%
CHRNA5
9%
Genotyping
9%
Gene Linkage Disequilibrium
9%
Candidate Gene
9%
Rare Variant
8%
Telomere
8%
BRCA2
8%
Major Histocompatibility Complex
8%
DNA Repair
7%
Human Leukocyte Antigen
7%
Case-Control Study
7%
Titer
7%
Allele
6%
Germline Mutation
6%
FANCA
6%
Functional Genomics
6%
IRF5
6%
Passive Smoking
6%
Twin Pregnancy
6%
Tag SNP
6%
TERF1
6%
Quantitative Trait
6%
Codon
6%
WIF1
6%
MHC Class I
6%
Genetic Polymorphism
6%
Blood Level
6%
HLA-DRB1
6%
Sepsis-Induced Critical Illness Neuropathy
6%
Telomere Length
6%
Cohort Study
6%
Mendelian Randomization
6%
Rheum
6%
Missense
6%
Cell Cycle
6%
Immunology and Microbiology
Single Nucleotide Polymorphism
70%
Genome-Wide Association Study
58%
Inflammatory Arthritis
39%
Allele
18%
Human Leukocyte Antigen
16%
Autoimmune Disease
16%
Systemic Scleroderma
13%
Dermatomyositis
12%
Haplotype
11%
Genetic Risk
9%
Promoter Region
8%
DNA Repair
7%
Epitope
7%
Major Histocompatibility Complex
7%
HLA DRB1 Antigen
7%
Mitogen
6%
Adaptive Immune System
6%
Programmed Cell Death
6%
Cell Cycle
6%
Myositis
6%
MHC Class I
6%
Lod Score
6%
Blood Level
6%
Genetic Variation
6%
Alopecia Areata
6%
Chromosome 5
6%
Genetic Polymorphism
6%
Whole Genome Sequencing
6%
